These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33329597)

  • 1. Editorial: γδ T Cells in Cancer.
    Coffelt SB; Kabelitz D; Silva-Santos B; Kuball J; Born W; Bank I
    Front Immunol; 2020; 11():602411. PubMed ID: 33329597
    [No Abstract]   [Full Text] [Related]  

  • 2. γδ T cells in cancer immunotherapy.
    Zou C; Zhao P; Xiao Z; Han X; Fu F; Fu L
    Oncotarget; 2017 Jan; 8(5):8900-8909. PubMed ID: 27823972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions.
    Cazzetta V; Bruni E; Terzoli S; Carenza C; Franzese S; Piazza R; Marzano P; Donadon M; Torzilli G; Cimino M; Simonelli M; Bello L; Villa A; Tan L; Ravens S; Prinz I; Supino D; Colombo FS; Lugli E; Marcenaro E; Vivier E; Della Bella S; Mikulak J; Mavilio D
    Cell Rep; 2021 Oct; 37(3):109871. PubMed ID: 34686325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial: Understanding Gamma Delta T Cell Multifunctionality - Towards Immunotherapeutic Applications.
    Gustafsson K; Herrmann T; Dieli F
    Front Immunol; 2020; 11():921. PubMed ID: 32477369
    [No Abstract]   [Full Text] [Related]  

  • 5. Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release.
    Park JA; Santich BH; Xu H; Lum LG; Cheung NV
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33986124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of gamma/delta T cells for solid tumor immunotherapy.
    Zhu D; Ren X; Xie W; Chen J; Liang S; Jiang M; Wang J; Zheng Z
    Front Immunol; 2024; 15():1466266. PubMed ID: 39253082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.
    Li Y; Li G; Zhang J; Wu X; Chen X
    Front Immunol; 2020; 11():619954. PubMed ID: 33664732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy with γδ T-cells: the future is there.
    Kabelitz D; Yin Z
    Immunotherapy; 2024; 16(11):705-708. PubMed ID: 38940301
    [No Abstract]   [Full Text] [Related]  

  • 9. Unlocking γδ T cell power: pathways that boost cancer defense.
    Yao Y; Zong Z; Zhang L
    Mol Biomed; 2024 Feb; 5(1):5. PubMed ID: 38311633
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor hypoxia represses γδ T cell-mediated antitumor immunity against brain tumors.
    Park JH; Kim HJ; Kim CW; Kim HC; Jung Y; Lee HS; Lee Y; Ju YS; Oh JE; Park SH; Lee JH; Lee SK; Lee HK
    Nat Immunol; 2021 Mar; 22(3):336-346. PubMed ID: 33574616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging Protumor role of γδ T lymphocytes: implications for cancer immunotherapy.
    Rei M; Pennington DJ; Silva-Santos B
    Cancer Res; 2015 Mar; 75(5):798-802. PubMed ID: 25660949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Effects of γδ T Cells in Colorectal Cancer: A Review.
    Ma R; Yuan D; Guo Y; Yan R; Li K
    Front Immunol; 2020; 11():1600. PubMed ID: 33013819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and metabolic dichotomy of murine γδ T cell subsets in cancer immunity.
    Lopes N; Silva-Santos B
    Eur J Immunol; 2021 Jan; 51(1):17-26. PubMed ID: 33188652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between γδ T cells and neutrophils in cancer: knowns and unknowns.
    Hao J; Granot Z
    J Leukoc Biol; 2024 May; 115(6):993-995. PubMed ID: 38498617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.
    Cordova A; Toia F; La Mendola C; Orlando V; Meraviglia S; Rinaldi G; Todaro M; Cicero G; Zichichi L; Donni PL; Caccamo N; Stassi G; Dieli F; Moschella F
    PLoS One; 2012; 7(11):e49878. PubMed ID: 23189169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends.
    Barros MS; de Araújo ND; Magalhães-Gama F; Pereira Ribeiro TL; Alves Hanna FS; Tarragô AM; Malheiro A; Costa AG
    Front Immunol; 2021; 12():729085. PubMed ID: 34630403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-cancer γδ TCR analysis uncovers clonotype diversity and prognostic potential.
    Yu X; Song L; Cen L; Cao B; Tao R; Shen Y; Abate-Daga D; Rodriguez PC; Conejo-Garcia JR; Wang X
    Cell Rep Med; 2024 Oct; 5(10):101764. PubMed ID: 39368482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key players of immunosuppression in epithelial malignancies: Tumor-infiltrating myeloid cells and γδ T cells.
    Tamuli B; Sharma S; Patkar M; Biswas S
    Cancer Rep (Hoboken); 2024 May; 7(5):e2066. PubMed ID: 38703051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrophilin-like proteins display combinatorial diversity in selecting and maintaining signature intraepithelial γδ T cell compartments.
    Jandke A; Melandri D; Monin L; Ushakov DS; Laing AG; Vantourout P; East P; Nitta T; Narita T; Takayanagi H; Feederle R; Hayday A
    Nat Commun; 2020 Jul; 11(1):3769. PubMed ID: 32724083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. γδ T Cells: Unexpected Regulators of Cancer Development and Progression.
    Fleming C; Morrissey S; Cai Y; Yan J
    Trends Cancer; 2017 Aug; 3(8):561-570. PubMed ID: 28780933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.